BioVaxys Technology Corp. C.BIOV

Alternate Symbol(s): BVAXF

Healthcare Biotechnology

BioVaxys Technology Corp. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on improving patient lives with novel immunotherapies based on the DPX immune-educating technology platform and its HapTenix neoantigen tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization and other immunological fields. The Company's clinical-stage pipeline includes maveropepimut-S, which is in phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using its HapTenix neoantigen tumor cell construct platform for treating refractive late-stage ovarian cancer. The Company is also leveraging its expertise in tumor immunology by creating a unique library of T-lymphocytes and other datasets post-vaccination with its personalized immunotherapeutic vaccines to identify new targetable tumor antigens.

CSE:BIOV - Post by User

BioVaxys Technology Corp. > Asks were at .07 at close Last trades at close CDN

<< Previous

Bullboard Posts

Next >>

Post by frankmanon Dec 20, 2024 4:05pm

45 Views

Post# 36372881

Asks were at .07 at close Last trades at close CDN

Time ET	Ex	Price	Change	Volume	Buyer	Seller
15:59:15	C	0.065	0.005	1,000	1 Anonymous	80 National Bank
15:57:07	C	0.065	0.005	28,000	1 Anonymous	1 Anonymous
15:50:03	C	0.065	0.005	30,000	1 Anonymous	1 Anonymous
15:28:42	H	0.065	0.005	5,000	88 Credential	1 Anonymous
15:28:42	D	0.065	0.005	200	88 Credential	14 Virtu ITG
15:28:25	C	0.065	0.005	500	1 Anonymous	80 National Bank
15:28:25	H	0.065	0.005	1,000	1 Anonymous	1 Anonymous
15:25:46	C	0.065	0.005	12,000	1 Anonymous	1 Anonymous
15:25:41	C	0.065	0.005	15,000	79 CIBC	1 Anonymous
15:24:03	M	0.065	0.005	750	39 Merrill Lynch	14 Virtu ITG